Chemical Structure (Topiramate 01)
Topiramate Capsule, Extended Release
Product Images NDC 0832-1071
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 0832-1071). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Topiramate 02)
Figure 2 (Topiramate 03)
Figure 3 (Topiramate 04)
This text seems to represent the results of a study comparing the effectiveness of topiramate and placebo for the treatment of migraines. The study involved several groups of participants taking different dosages of topiramate or placebo, and the average monthly migraine frequency was measured. The study found that topiramate was significantly more effective than placebo in reducing the frequency of migraines, with the p-value being less than 0.010. Two asterisks indicate that this result was highly significant (p < 0.001).*
Principal Display Panel (25 mg Capsule Bottle Label)
NBC 0832-1071-20 is a medication that contains Topiramate 25 mg in each capsule, and is intended for once-daily dosing. It is recommended to keep the medication out of reach of children and store it in a tightly sealed container at 20°C to 25°C. The medication should be dispensed separately to each patient by a pharmacist, and should be protected from moisture. The medication is manufactured by Upsher-Smith Laboratories, and the package contains 20 capsules.*
Principal Display Panel (50 mg Capsule Bottle Label)
Principal Display Panel (100 mg Capsule Bottle Label)
This is a prescription drug called Topiramate with strength of 100mg. It comes in a container with 30 capsules and is recommended to be taken once daily. The prescribing information should be consulted before using. The capsules should be kept in a tight container at a temperature of 20° to 25°C and protected from moisture. It should be kept out of reach of children. Upsher-Smith Laboratories, LLC manufactures the drug and provides a guide to each patient separately.*
Principal Display Panel (150 mg Capsule Bottle Label)
This is a prescription drug with the NDC code 0832-1075-30. Each capsule contains 150mg of Topiramate for daily dosing. The recommended dose is one capsule per day. It is important to keep out of reach of children, store in a tight container at a temperature between 20°C to 25°C (68°F to 77°F) with permitted excursions to 15°C to 30°C (59°F to 86°F) and protect from moisture. This medication is manufactured by Upsher-Smith Laboratories, LLC, with specific dispensing instructions provided to patients separately.*
Principal Display Panel (200 mg Capsule Bottle Label)
This is a prescription medication with the NDC code 0832-1073-30. It contains 30 capsules of Topiramate 200mg for once-daily dosing. Users are advised to keep it in a tight container at a temperature range of 20° to 25°C (68° to 77°F) and protect it from moisture. The manufacturer is Upsher-Smith Laboratories, LLC, and the medication should be dispensed by a pharmacist. A patient guide is included with each purchase. The prescribing information should be consulted before using the medication.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
